Author:
Shiu Eunice Y.C.,Cheng Samuel M.S.,Martín-Sánchez Mario,Au Niki Y.M.,Chan Karl C.K.,Li John K.C.,Fung Lison W.C.,Luk Leo L.H.,Chaothai Sara,Kwan Tsz Chun,Ip Dennis K.M.,Leung Gabriel M.,Poon Leo L.M.,Peiris J.S. Malik,Leung Nancy H.L.,Cowling Benjamin J.
Reference17 articles.
1. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study;McMenamin;Lancet Infect Dis,2022
2. Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: analyses of routinely-collected data on vaccine coverage and mortality;Victora;EClinical Med,2021
3. Strength and durability of antibody responses to BNT162b2 and CoronaVac;Cowling;Vaccine,2022
4. Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals;Muena;EBio Med,2022
5. Immunogenicity of a third dose of BNT162b2 to ancestral severe acute respiratory syndrome coronavirus 2 and the omicron variant in adults who received 2 doses of inactivated vaccine;Leung;Clin Infect Dis,2023